Purpose: This study aimed to assess insulin resistance (IR) and diabetes
risk levels using the FINDRISK noninvasive assessment tool in physicians
from a tertiary care hospital. Methods: A cross-sectional study was
carried out between February-April 2013 on 200 physicians working in a
tertiary. Data was collected using the Finnish diabetes risk score
(FINDRISK) tool, fasting blood glucose (FBG), and fasting insulin. The
Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) was
calculated. Results: Age was 25-45 years in 84.5% (n=169) of the
physicians. Half of the participants were consultants, while the
remaining were residents. Mean blood insulin, glucose, and HOMA-IR
levels of the participants were 14.04±13.38 IU/mL, 93.55±10.11 mg/dl,
and 3.39±3.64, respectively. Most of the participants (58.0%, n=116)
were males. The FINDRISK categories were low in 16.5% (n=32), mild in
36.5% (n=73), moderate in 23.5% (n=47), high in 18.5% (n=37), and
very high in 5.5% (n=11). HOMA-IR was 2.6-33 in 49.5% (n=99), while
impaired fasting glucose (IFG) was present in 24% (n=48) of the
doctors. Majority of the physicians (77.5%, n=155) had a body mass
index (BMI) of ≥ 25 kg/m2, did not exercise regularly (89.0%, n=178),
did not consume daily vegetables and/or fruits (62.5%, n=125), and had
diabetic relatives (72.0%, n=144). The risk of diabetes was higher
among the consultants compared to the residents (p=0.001), which
persisted even after controlling for age. Conclusions: Our findings
suggest that the FINDRISK assessment may use in the screening of medical
doctors for diabetes in Turkey. Diabetes is more prevalent among
hypertensive physicians. Projects are needed to modify the reversible
diabetes risk factors among medical doctors.